Market Cap | 16.56M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -6.71M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 9.00% |
Sales | 265.48k | PEG | - | EPS past 5Y | - | 200D Avg Chg | 32.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -32.00% |
Recommedations | - | Quick Ratio | 0.02 | Shares Outstanding | 162.48M | 52W Low Chg | 199.00% |
Insider Own | 14.03% | ROA | -84.30% | Shares Float | 101.91M | Beta | 3.09 |
Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.15 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 273,717 | Target Price | - |
Oper. Margin | 116.63% | Earnings Date | - | Volume | 80,000 | Change | 1.36% |
Promino Nutritional Sciences Inc., a nutraceutical company, develops nutritional products in Canada and the United States. The company offers Rejuvenate, a proprietary formulation to assist in the rebuilding, restoration, and rejuvenation of natural loss of muscle mass due to aging or other medical conditions; and PROMINO, an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength, and accelerate recovery from injury. It also engages in retailing of its products through stores and online. The company was formerly known as Element Nutritional Sciences Inc. and changed its name to Promino Nutritional Sciences Inc. in January 2024. Promino Nutritional Sciences Inc. was founded in 2015 and is based in Burlington, Canada.